Order Hyalgan® for Clinics

Hyalgan® is a sodium hyaluronate viscosupplement supplied as a sterile prefilled syringe for intra-articular administration to the knee. Licensed clinics and healthcare professionals can order Hyalgan®(English) for professional use in osteoarthritis knee injection programs. The ready-to-use syringe format supports treatment-room preparation, lot tracking, and consistent procedure workflows.

Med Wholesale Supplies serves licensed clinical facilities that need authentic, brand-name medical products for scheduled procedures. Hyalgan is used by orthopedic, rheumatology, sports medicine, and interventional pain teams that maintain structured protocols for knee osteoarthritis care.

Hyalgan Price, Ordering, and Clinic Documentation

Sign in to view current Hyalgan price information for your clinic account. Pricing can vary by contracted terms, order volume, and product presentation shown during checkout. Procurement teams should match the unit selected during ordering to the practice protocol and internal inventory records.

Orders are intended for licensed clinics, healthcare professionals, ambulatory surgery centers, and hospital departments that administer intra-articular injections in controlled clinical settings. Professional documentation or facility verification may apply before release. Our team can help align product descriptions, lot records, and reorder planning with your internal purchasing process.

Quick tip: Keep lot number, expiration date, receiving date, and procedure-area location in the same inventory record to simplify traceability.

What Hyalgan Is Used For

Hyalgan is a sodium hyaluronate intra-articular injection used for pain associated with osteoarthritis of the knee. Hyaluronate is a substance found in synovial fluid, the fluid that helps lubricate and cushion joints. In osteoarthritic knees, supplementation may support the viscoelastic properties of joint fluid when administered by trained clinicians.

This product is not a corticosteroid. It is generally described as a viscosupplement because its role is mechanical lubrication and cushioning within the joint space, rather than a steroid anti-inflammatory mechanism. Clinicians typically consider it within a broader care plan that may include exercise guidance, bracing, physical therapy, oral analgesics, and patient-specific activity modification.

Providers standardizing joint-care supplies can browse the Orthopedic Injections category for related intra-articular products. Rheumatology practices may also use the Rheumatology category when organizing injection therapies and adjacent clinic supplies.

Form, Active Ingredient, and Mechanism

The active ingredient is sodium hyaluronate, also known as hyaluronic acid or hyaluronan. Hyalgan is supplied as a sterile, single-use prefilled syringe for knee joint administration by qualified professionals. Use the strength, concentration, and quantity displayed during ordering to match the approved clinic protocol and product label.

The syringe is designed to reduce preparation steps compared with drawing medication from a vial. A prefilled presentation can also help maintain consistency in tray setup, reduce handling variability, and support staff training across multiple procedure rooms. It should not be re-entered, reused, or shared between patients.

Some procurement teams identify the class as sodium hyaluronate intra-articular therapy, sodium hyaluronate prefilled syringe, or Hyalgan intra-articular injection. These terms describe the professional-use category and should be reconciled with the exact product name and presentation shown on purchasing and receiving documents.

Professional Administration and Workflow Fit

Hyalgan is administered into the knee joint space by a trained healthcare professional. Aseptic technique is essential because intra-articular injections enter a normally sterile joint environment. Clinicians should follow the manufacturer’s instructions, facility protocol, and any applicable professional standards for preparation, skin antisepsis, needle selection, joint access, and post-procedure observation.

Orthopedic and rheumatology teams often schedule viscosupplementation as part of a series, with timing guided by the product label, clinician judgment, and patient response. The prefilled syringe format helps practices build consistent procedure kits and reduce last-minute preparation. Staff can coordinate appointment schedules, stock levels, and documentation before each injection session.

For more context on clinical planning, see tailoring Hyalgan injection plans and Hyalgan with physical therapy. These articles can support internal education, but treatment decisions should remain under the direction of the treating clinician.

Key Product Features for Clinics

• Sodium hyaluronate viscosupplement for intra-articular knee administration.
• Sterile prefilled syringe format for single-patient professional use.
• Designed for controlled clinical settings such as outpatient injection suites.
• Non-steroidal treatment category focused on joint fluid supplementation.
• Lot and expiration labeling supports receiving, storage, and traceability.
• Procedure-ready format can standardize tray setup and staff workflow.
• Appropriate for orthopedic, rheumatology, sports medicine, and pain practices.

The product presentation supports clinics that need repeatable workflows across providers. Inventory teams can plan reorder points around scheduled knee injection sessions, while clinical staff can prepare procedure areas using consistent product identifiers.

Storage, Handling, and Receiving

Store Hyalgan according to the manufacturer’s package insert and the labeling supplied with the product. Keep the syringe in its protective packaging until use, protect it from contamination, and inspect the solution before administration. Do not use the syringe if the package integrity is compromised, the expiration date has passed, or the solution appears discolored or contains visible particulate matter.

Receiving staff should document the lot number, expiration date, quantity, and storage location when inventory arrives. For multi-site groups, standardized receiving procedures help maintain consistent records across locations. When required for the product or shipment conditions, Med Wholesale Supplies uses temperature-controlled handling when required and tracked US delivery.

Why it matters: Clear receiving records help clinical teams connect the administered product to the correct lot and expiration details.

Safety, Contraindications, and Monitoring

Hyalgan is for professional use only. It should not be administered into an infected knee joint or through infected or diseased skin in the injection area. The product should not be used in patients with known hypersensitivity to hyaluronate preparations or relevant product components. Hyaluronan products may be associated with avian-source considerations, so clinicians should review labeling for allergy precautions, including hypersensitivity to avian proteins when applicable.

Expected local reactions can include transient injection-site pain, swelling, warmth, bruising, stiffness, or mild effusion. Some patients may experience temporary worsening of knee discomfort after the injection. Serious reactions are less common but require prompt clinical evaluation, especially if severe pain, marked swelling, fever, or signs of infection occur.

After administration, clinicians commonly advise patients to avoid strenuous or high-impact activity for at least 48 hours, consistent with product guidance and local protocol. Teams should document patient counseling, the injected joint, lot number, dose details from the syringe label, and any immediate post-procedure observations.

Drug interaction concerns are mainly procedural and product-specific rather than systemic. Clinicians should avoid mixing intra-articular products unless the label and facility protocol support it. Anticoagulation status, skin integrity, recent joint procedures, active synovitis, infection risk, and allergy history should be considered before administration.

Clinical Expectations and Patient Counseling Points

Patients and clinics often ask how long Hyalgan injection effects last. Response timing and duration can vary by patient, disease severity, injection schedule, and concurrent care plan. The product should not be positioned as a cure for osteoarthritis, and outcomes should be monitored over the course of the treatment plan.

Before each injection session, staff can confirm the target knee, consent process, relevant allergies, prior reactions, and any interval clinical changes. After the procedure, provide clear activity guidance and contact instructions for concerning symptoms. This practical counseling can reduce confusion and supports consistent patient experience across providers.

For educational background on hyaluronic acid in joint programs, the article Hyalgan and hyaluronic acid for joint health discusses the therapy category in more detail.

Packaging and Supply Planning

Hyalgan is supplied as a unit-dose prefilled syringe for intra-articular knee injection. Each unit should remain associated with its lot and expiration details from receipt through administration. Clinics with frequent viscosupplementation appointments may benefit from separating procedure-ready inventory from reserve stock while maintaining the same storage requirements.

Facilities may categorize this product under Hyalgan prefilled syringe, Hyalgan knee injection, or sodium hyaluronate intra-articular therapy in internal systems. Use consistent naming across purchasing, receiving, billing, and procedure documentation to reduce reconciliation errors. The Hyalgan brand section can help purchasing staff locate related Hyalgan entries.

Comparable Sodium Hyaluronate and HA Options

Clinics evaluating viscosupplementation formularies often review other hyaluronic acid products with different presentations, concentrations, or scheduling protocols. Selection depends on clinician preference, patient selection criteria, clinic workflow, and product labeling. Do not substitute across products without clinical leadership approval and documentation updates.

Common alternatives in the same broader category include Orthovisc, Durolane, Monovisc, and Euflexxa. For broader comparison content, see Hyalgan vs Synvisc and Hyalgan vs Euflexxa.

Authoritative Sources

• Manufacturer information
• NIAMS osteoarthritis overview
• Peer-reviewed clinical trial record

Important Use Information

Use Hyalgan only in accordance with the manufacturer’s labeling and facility protocol. Confirm the product, joint, patient allergy history, skin condition, and procedure documentation before administration. Maintain aseptic technique, verify intra-articular placement, and monitor for immediate local reactions after injection.

Clinical leaders should define substitution rules, staff training expectations, and inventory documentation before adding or changing viscosupplement products. Ordering teams should coordinate purchasing with scheduled clinic volume so treatment sessions are not disrupted by avoidable inventory gaps.

This content is for informational purposes only and is not a substitute for professional medical advice.